Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.0 and the previous Revision: v3.4.3 listing has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:07:19.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page; the previous tag was removed.
    Difference
    0.1%
    Check dated 2026-03-11T16:47:02.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a related topic entry for generalized pustular psoriasis and a link to Genetic and Rare Diseases Information Center resources for this condition.
    Difference
    0.2%
    Check dated 2026-02-25T09:17:39.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a new site revision tag 'Revision: v3.4.2' and removal/update of prior system notices (including a government funding/operating status notice and 'Revision: v3.4.1'). These are administrative updates and do not modify study content or its presentation.
    Difference
    0.4%
    Check dated 2026-02-11T05:44:46.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a clinical study report synopsis, sponsor information (AbbVie), Helpful Links, and a site revision note (Revision: v3.4.1). Removed the previous revision (Revision: v3.4.0) and included a government funding notice for currency of information.
    Difference
    0.6%
    Check dated 2026-02-04T05:31:38.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T03:50:35.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.